{"id":"W2746874591","doi":"10.1161/circulationaha.117.028136","title":"Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors","year":2017,"lang":"en","type":"review","venue":"Circulation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":580,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Banting and Best Diabetes Centre, University of Toronto; Medicines Company; Novo Nordisk; Intarcia Therapeutics; Sanofi; GlaxoSmithKline; Servier; Pfizer; Canada Research Chairs; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Semaglutide; Lixisenatide; Alogliptin; Saxagliptin; Liraglutide; Glucagon-like peptide 1 receptor; Internal medicine; Diabetes mellitus; Exenatide; Sitagliptin; Dipeptidyl peptidase-4; Type 2 diabetes; Myocardial infarction; Pharmacology; Endocrinology; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003454563,0.0006265231,0.001434628,0.0008826534,0.0002839971,0.0007974812,0.0004034658,0.0008580551,0.002462456],"category_scores_gemma":[0.004640573,0.0001925627,0.001837531,0.001376373,0.000468678,0.000822451,0.0004787867,0.001637648,0.0004793422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004200466,"about_ca_system_score_gemma":0.0004364505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005020261,"about_ca_topic_score_gemma":0.0009168395,"domain_scores_codex":[0.9980768,0.0008383382,0.0002099326,0.0002704541,0.0004306889,0.0001737784],"domain_scores_gemma":[0.9955515,0.001311879,0.001625363,0.000188113,0.0004584259,0.0008647087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"systematic_review","study_design_scores_codex":[0.228654,0.00441091,0.495767,0.003496157,0.01325204,0.000697145,0.0001810419,0.002101587,0.004348296,0.0008858545,0.004433794,0.2417722],"study_design_scores_gemma":[0.006729354,0.03701595,0.9391994,0.0003530282,0.006972967,0.0007496992,0.0001311579,0.0009581651,0.0008905815,0.001196507,0.005717696,0.00008541245],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7868801,0.1830279,0.001143773,0.001677708,0.000588363,0.0003129865,0.004080384,0.000108846,0.02218],"genre_scores_gemma":[0.9667009,0.02405005,0.0008651139,0.0008514356,0.001229106,0.0003441314,0.00396536,0.00001329672,0.001980459],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003454563,"threshold_uncertainty_score":0.01826972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1037989692238348,"score_gpt":0.3727103154527517,"score_spread":0.2689113462289168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}